TCM Share Price | TCM Stock Screener
TCMLMTD
Commodity Chemicals
Share Price BSE
₹43.40
▲
0.84 (1.97%)
As of July 24, 2026, the TCM share price (BSE: TCMLMTD) is ₹43.40, up 1.97% from the previous close, with shares trading between ₹42.50 and ₹43.40, and a 52-week range of ₹37.21–₹74.33.
Analyse TCMLMTD share price data and track historical price performance.
Use the TCM stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
TCM Market Cap
₹33.24 Cr.
TCMLMTD P/E Ratio (TTM)
-5.33
TCM P/B Ratio
1.29
EPS (TTM)
₹-7.77
Dividend Yield
-
Debt to Equity
0.19
TCMLMTD 52 Week High
₹74.33
TCM 52 Week Low
₹37.21
Operating Margin
-24.00%
Profit Margin
-40.00%
TCMLMTD Revenue (TTM)
₹5.00
EBITDA
₹-1.00
Net Income
₹-2.00
Total Assets
₹83.00
Total Equity
₹25.00
TCM Share Price Chart
Screen TCM share price with an interactive chart. Analyse TCMLMTD price trends and volatility across different timeframes.
TCM Company Profile - Fundamental Screener
Screen TCM company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TCMLMTD shares.
Sector
Chemicals
Industry
Commodity Chemicals
Sub-Sector
Commodity Chemicals
Segment
E
ISIN
INE034F01010
TCM Balance Sheet Screener
Screen TCMLMTD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 83 | 76 | 84 | 69 | 61 | 68 | 65 | 69 |
| Current Assets | 63 | 42 | 46 | 10 | 5 | 6 | 5 | 9 |
| Fixed Assets | 17 | 14 | 17 | 36 | 55 | 59 | 58 | 58 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 9 | 0 | 20 | 20 | 20 | 20 | 20 | 20 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 25 | 29 | 28 | 30 | 24 | 33 | 33 | 32 |
| Share Capital | 8 | 8 | 8 | 8 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 17 | 23 | 21 | 23 | 22 | 29 | 29 | 29 |
TCM Income Statement Screener - Profit & Revenue Analysis
Screen TCM income statement and profit fundamentals.
Analyze TCMLMTD quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for TCM share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 12 | 3 | 7 | 6 | 9 | 5 | 7 | 6 | 5 | 7 | 5 | 11 | 2 | 1 |
| Expenses | 6 | 8 | 5 | 7 | 6 | 9 | 6 | 8 | 7 | 6 | 8 | 7 | 11 | 6 | 2 |
| EBITDA | -1 | 4 | -2 | 0 | -1 | 0 | -1 | -1 | -1 | -1 | -1 | -2 | 1 | -4 | -1 |
| Operating Profit % | -24.00% | 1.00% | -61.00% | -14.00% | -10.00% | -8.00% | -20.00% | -8.00% | -10.00% | -15.00% | -10.00% | -33.00% | 7.00% | -331.00% | -182.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -2 | 4 | -2 | -1 | -1 | 0 | -1 | -1 | -1 | -1 | -1 | -2 | 1 | -4 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -2 | 4 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | 1 | -4 | -1 |
| EPS | -2.20 | 5.39 | -3.00 | -1.05 | -1.53 | -0.48 | -1.31 | -0.77 | -1.16 | -1.35 | -0.89 | -2.21 | 0.98 | -11.76 | -1.51 |
TCM Cash Flow Screener - Liquidity Fundamentals
Screen TCMLMTD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -10 | 2 | -11 | -4 | 0 | -1 | -2 |
| Investing Activities | 0 | -1 | 6 | 4 | -1 | 0 | 0 |
| Financing Activities | 10 | -1 | 5 | 0 | 0 | -3 | 5 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | -4 | 4 |
TCM Shareholding Pattern Screener
See TCM shareholding pattern with promoter, FII, and DII holdings.
Check TCM promoter holding and ownership changes for TCMLMTD on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 49.51% | 49.51% | 49.51% | 49.51% | 49.51% | 49.51% | 49.51% | 49.51% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 7.44% | 7.44% | 7.44% | 7.44% | 7.44% | 7.44% | 7.71% | 7.44% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.35% | 38.98% | 38.80% | 38.77% | 38.79% | 38.39% | 36.91% | 38.57% |
| Other Holding | 4.70% | 4.07% | 4.25% | 4.28% | 4.26% | 4.66% | 5.87% | 4.48% |
| Shareholder Count | 4,198 | 4,160 | 4,590 | 4,513 | 4,564 | 4,272 | 3,972 | 3,991 |
TCM Share Dividend Screener - Share Yield Analysis
Check TCM dividend history with payout and yield data.
View TCM dividend details including ex-dates and amounts for TCMLMTD stock.
TCM Stock Index Membership
See which indices include TCM stock.
Check TCMLMTD index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
TCM Market Events Screener - Corporate Actions
Get TCM corporate actions including splits, bonuses, and buybacks.
Check TCM stock events that may affect TCMLMTD share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | -2.70% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 2.25% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 18.24% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | 5.35% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | 1.66% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -0.05% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -3.67% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 3.11% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 7.39% |
| 2023-11-22 | 2023-11-22 | Extraordinary General Meeting | NA | -19.35% |
| 2023-09-29 | 2023-09-29 | Annual General Meeting | NA | -1.29% |
| 2022-07-29 | 2022-07-29 | Extraordinary General Meeting | NA | 15.39% |
| 2022-04-26 | 2022-04-27 | Rights | 6:5 | 21.40% |
TCM Competitors Screener - Peer Comparison
Screen TCMLMTD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Deepak Fertilisers & Petrochemicals | 19,968 | 27.29 | 11,506 | 11.11% | 725 | 57.58 |
| Tata Chemicals | 17,672 | -10.37 | 14,900 | -1.40% | -1,715 | 42.28 |
| Gujarat Narmada Valley Fert & Chem | 7,468 | 9.14 | 7,773 | -7.39% | 753 | 43.89 |
| TANFAC Industries | 5,752 | 81.17 | 711 | 27.00% | 73 | 76.36 |
| Gujarat Alkalies & Chemicals | 4,433 | -1778.94 | 4,358 | 4.64% | 20 | 37.38 |
| GHCL | 4,023 | 8.45 | 3,138 | -4.08% | 473 | 46.59 |
| Grauer & Weil | 3,453 | 21.54 | 1,190 | 0.86% | 168 | 51.86 |
| Chemplast Sanmar | 3,147 | -11.05 | 4,252 | -3.21% | -280 | 40.22 |
| Fischer Medical Ventures | 2,588 | 83.85 | 309 | 175.03% | 30 | 58.00 |
| Thirumalai Chemicals | 1,960 | -11.83 | 1,754 | -15.26% | -168 | 42.24 |
TCM Company Announcements - News Screener
Screen TCMLMTD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-26 | Board Meeting Outcome for Outcome Of Board Meeting Held On 26Th May 2026 And Audited Consolidated And Standalone Financial Results For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-20 | Board Meeting Intimation for Consideration And Approval Of The Consolidated And Standalone Audited Financial Statements For The Quarter And Year Ended 31St March 2026 | - |
| 2026-04-30 | Corporate Update-Cancellation Of Order | - |
| 2026-04-22 | Disclosure/Declaration Under Regulation 31(4) Of SEBI(SAST) Regulations 2011 For The FY Ended 31St March 2026 From The Promoters Of The Company | - |
| 2026-04-22 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-17 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-17 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday 17Th February 2026 | - |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th February 2026 And The Consolidated And Standalone Unaudited Financial Results Along With The Consolidated And Standalone Limited Review Reports For The Quarter Ended 31St December 2025 | - |
| 2026-02-03 | Board Meeting Intimation for The Consideration And Approval Of The Consolidated And Standalone Financial Results For The Quarter Ended 31St December 2025 | - |
| 2026-01-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-31 | Closure of Trading Window | - |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-11 | Board Meeting Outcome for And The Consolidated And Standalone Unaudited Financial Results Along With The Consolidated And Standalone Limited Review Reports For The Quarter Ended 30Th September 2025 | - |
| 2025-11-10 | Intimation Under Regulation 30 Of The SEBI(LODR) Regulations 2015 For Opening Of The Healthcare Division Office Of The Company | - |